
Dana Sarnak, PhD, and Wen Shen, MD, comment on a Johns Hopkins analysis showing rising menopause hormone therapy use among midlife women.
Insertion of a levonorgestrel intrauterine system (LNG-IUS) can reverse abnormal endometrial cell growth, according to the results of a small study in high-risk patients, suggesting that the device may have potential in treatment of women with early-stage endometrial cancer who are not candidates for surgery.





